TORONTO, April 22, 2024 /CNW/ - CareRx Corporation ("CareRx" or the "Company") (TSX: CRRX), Canada's leading provider of pharmacy services to seniors living communities, hosted the Honourable Doug Ford, Premier of Ontario, at the Company's Oakville pharmacy on April 18, 2024, to showcase CareRx's leadership in technology and innovation in support of improving healthcare outcomes for residents in long-term care homes across Ontario.
The Premier was joined by the Honourable Stan Cho, Minister of Long-Term Care, Stephen Crawford, MPP (Oakville) and Effie Triantafilopoulos, MPP (Oakville North—Burlington).
Alongside several senior leaders from CareRx's home operating partners, the delegation received a demonstration of CareRx's automated high-volume medication packaging equipment, optical verification robotics and use of Lean management principles that drive continuous improvement in pharmacy operations. CareRx team members were proud to share personal stories of their commitment to ensuring safe and efficient medication management for seniors.
"We would like to extend our gratitude to the Ontario Government for their continued support of long-term care pharmacy service providers," said Puneet Khanna, President and Chief Executive Officer of CareRx. "This visit underscores our combined commitment to supporting seniors in Ontario and to driving innovation and improving healthcare for our community. We look forward to forging an even stronger partnership in the future."
CareRx is Canada's leading provider of pharmacy services to seniors living communities. We serve approximately 91,000 residents in over 1,500 seniors and other congregate care communities (long-term care homes, retirement homes, assisted living facilities, and group homes). We are a national organization with a large network of pharmacy fulfillment centres strategically located across the country. This allows us to deliver medications in a timely and cost-effective manner and quickly respond to routine changes in medication management. We use best-in-class technology that automates the preparation and verification of multi-dose compliance packaging of medication, providing the highest levels of safety and adherence for individuals with complex medication regimens. We take an active role in working with our home operator partners to promote resident health, staff education, and medication system quality and efficiency.
Last Trade: | C$2.62 |
Daily Change: | -0.03 -1.13 |
Daily Volume: | 7,300 |
Market Cap: | C$166.340M |
March 05, 2025 November 08, 2024 August 08, 2024 May 10, 2024 April 04, 2024 |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MOREChimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREEnd of content
No more pages to load